Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.51 |
| ▸ | PPARA | Q07869 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375933 | 1.00 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL338001 | 1.00 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL1714102 | 1.00 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL1714197 | 1.00 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| Water SCHEMBL3347709 | 0.98 | PPARG (0.50) | PPARGPPARALMNAL3MBTL1KMT2A | |
| Water SCHEMBL2789432 | 0.98 | PPARG (0.50) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL27510640 | 0.90 | PPARG (0.45) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL11708010 | 0.90 | PPARG (0.53) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL1974348 | 0.88 | PPARG (0.54) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL2952466 | 0.88 | PPARG (0.54) | PPARGPPARALMNAL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110862-A9 | PROCESS FOR PREPARING ZANUBRUTINIB | OLON S.P.A. (IT) | 2024-11-28 | — | — | WO | claimed |
| CN-114698375-B | Process for preparing 2-cyanoethyl (4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyridine-3-carboxylate | 拜耳公司 | 2024-08-02 | — | — | CN | claimed |
| US-20240199599-A1 | PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE BY RESOLUTION OF RACEMATES BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-06-20 | — | — | US | claimed |
| WO-2024110862-A1 | PROCESS FOR PREPARING ZANUBRUTINIB | OLON S.P.A. (IT) | 2024-05-30 | — | — | WO | claimed |
| CN-114698375-A | Method for preparing 2-cyanoethyl (4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyridine-3-carboxylic ester by splitting racemic modification from diastereomeric tartrate | 拜耳公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113527202-A | Hydroxychloroquine sulfate crystal | 健亚生物科技股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| WO-2021074078-A1 | PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE BY RESOLUTION OF RACEMATES BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-04-22 | — | — | WO | claimed |
| EP-2831036-B1 | PROCESS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS | INTERVET INT BV (NL) | 2018-09-12 | — | — | EP | claimed |
| EP-1884514-B1 | METHOD FOR THE RESOLUTION OF 2-AMINO-6-PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOL AND INTERMEDIATE COMPOUNDS | CRYSTAL PHARMA SAU (ES) | 2017-04-12 | — | — | EP | claimed |
| US-9493400-B2 | Process for preparing fluoroleucine alkyl esters | MERCK SHARP & DOHME CORP. (US) | 2016-11-15 | — | — | US | claimed |
| WO-2008068569-A2 | PROCESSES FOR THE PREPARATION OF CLOPIDOGREL HYDROCHLORIDE | WOCKHARDT RESEARCH CENTRE (IN) | 2008-06-12 | — | — | WO | claimed |
| EP-1884514-A1 | METHOD FOR THE RESOLUTION OF 2-AMINO-6-PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOL AND INTERMEDIATE COMPOUNDS | Ragactives, S.L. (ES) | 2008-02-06 | — | — | EP | claimed |
| EP-1841774-A1 | PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENOÝ2,3b¨THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI | USV LIMITED (IN) | 2007-10-10 | — | — | EP | claimed |
| WO-2007083188-A2 | IMPROVED PROCESS FOR THE PREPARATION OF AN OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE | GLENMARK PHARMACEUTICALS LIMITED (US) | 2007-07-26 | — | — | WO | claimed |
| US-7109353-B2 | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-09-19 | — | — | US | claimed |
| WO-2006070387-A1 | PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENO[2,3b]THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-07-06 | — | — | WO | claimed |
| US-20060142595-A1 | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2006-06-29 | — | — | US | claimed |
| EP-1024137-B1 | RESOLUTION OF AMINES | ESTEVE LABOR DR (ES) | 2003-09-24 | — | — | EP | claimed |
| US-6187930-B1 | REACTING SELECTED AMINE WITH OPTICALLY ACTIVE ACID SELECTED FROM (+)-DITOLUYL-L-TARTARIC ACID AND/OR (-)-DITOLUYL-L-TARTARIC ACID IN SOLVENT TO FORM DIASTEROISOMERIC SALT, SEPARATING, ISOLATING ENANTIOMER | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2001-02-13 | — | — | US | claimed |
| EP-1024137-A1 | RESOLUTION OF AMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2000-08-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142595-A1 | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI | CA7, CYP3A7, CA2 | PPARG 3620/4885PPARA 3665/4885LMNA 2340/4885 |
| US-20240199599-A1 | PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE BY RESOLUTION OF RACEMATES BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS | MVD, VARS1, CYP4B1 | PPARG 854/4885PPARA 548/4885LMNA 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.